KMDA Kamada Ltd.
$8.05▲ +1.39%
Healthcare
Other
Volume 73.8K
Avg Volume (10D) 67.0K
Key Metrics & Fundamentals
Market Cap
$464.57M
P/E Ratio
21.2
Div Yield
2.14%
52W Range
6.55 - 9.35
% vs 50 MA
-1.81%
% vs 200 MA
0.33%
RSI-14
51.7
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.05
Free Cash Flow
$15.96M
Gross Rev
$54.92M
Gross Profit
$22.47M
EBITDA
$13.84M
COGS
$32.45M
Operating Exp
$12.96M
Operating Income
$9.51M
EBIT
$9.51M
Pretax Income
$10.19M
Net Income
$9.26M
EPS (Diluted)
0.16
Price & Volume History
Loading chart…
Recent News
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
GlobeNewswire · Oct 19, 2026 7:00 AM ET
Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel
MT Newswires · Oct 6, 2026 7:49 AM ET
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
GlobeNewswire · Oct 6, 2026 7:00 AM ET
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth
MarketBeat · Sep 27, 2026 8:01 AM ET
Kamada Maintains 'Sufficient' KedRAB Supply, Production Capacity Amid Increasing Rabies Exposures in US
MT Newswires · Sep 17, 2026 7:54 AM ET
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand
GlobeNewswire · Sep 17, 2026 7:00 AM ET
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 7:00 AM ET
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
GlobeNewswire · Sep 3, 2026 4:01 PM ET
Kamada (KMDA) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 10:30 AM ET
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
GlobeNewswire · Aug 17, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See KMDA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.